These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 15934594)

  • 1. [Numerous indications in cardiology. Beta receptor blockers can never be overlooked].
    MMW Fortschr Med; 2005 May; 147(18):57. PubMed ID: 15934594
    [No Abstract]   [Full Text] [Related]  

  • 2. Beta-blockers for heart failure: is slowing of heart rate essential?
    Tendera M
    Eur Heart J; 1999 Apr; 20(8):560-1. PubMed ID: 10337539
    [No Abstract]   [Full Text] [Related]  

  • 3. Nonselective versus selective beta-blockers in the management of chronic heart failure: clinical implications of the carvedilol or Metoprolol European Trial.
    Greenberg B
    Rev Cardiovasc Med; 2004; 5 Suppl 1():S10-7. PubMed ID: 15184835
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The merit of beta(1)-blockade in heart failure.
    Fagerberg B
    Eur Heart J; 1999 Dec; 20(24):1761-3. PubMed ID: 10581129
    [No Abstract]   [Full Text] [Related]  

  • 5. [Initial data on nebivolol in heart failure. Beta blockers strengthen older hearts, too].
    MMW Fortschr Med; 2003 May; 145(22):55. PubMed ID: 12866284
    [No Abstract]   [Full Text] [Related]  

  • 6. Expert consensus document on beta-adrenergic receptor blockers.
    López-Sendón J; Swedberg K; McMurray J; Tamargo J; Maggioni AP; Dargie H; Tendera M; Waagstein F; Kjekshus J; Lechat P; Torp-Pedersen C;
    Eur Heart J; 2004 Aug; 25(15):1341-62. PubMed ID: 15288162
    [No Abstract]   [Full Text] [Related]  

  • 7. Statistical issues relating to international differences in clinical trials.
    O'Shea JC; DeMets DL
    Am Heart J; 2001 Jul; 142(1):21-8. PubMed ID: 11431652
    [No Abstract]   [Full Text] [Related]  

  • 8. Beta-blockers and heart failure.
    Health News; 2000 Apr; 6(4):8. PubMed ID: 15356892
    [No Abstract]   [Full Text] [Related]  

  • 9. COMET: a proposed mechanism of action to explain the results and concerns about dose.
    Wikstrand J; Fagerberg B; Goldstein S; Kjekshus J; Wedel H
    Lancet; 2003 Sep; 362(9389):1076-7; author reply 1077-8. PubMed ID: 14522542
    [No Abstract]   [Full Text] [Related]  

  • 10. Effects of metoprolol on beta1 adrenergic receptor polymorphism and receptor density in urban Chinese patients with heart failure.
    Luo M; Bi Y; Xu YX
    Chin Med J (Engl); 2007 Oct; 120(19):1720-3. PubMed ID: 17935678
    [No Abstract]   [Full Text] [Related]  

  • 11. Benefit of beta-blockers for heart failure: proven in 1999.
    Sharpe N
    Lancet; 1999 Jun; 353(9169):1988-9. PubMed ID: 10376609
    [No Abstract]   [Full Text] [Related]  

  • 12. Synergistic polymorphisms of beta1 and alpha2C-adrenergic receptors and the influence on left ventricular ejection fraction response to beta-blocker therapy in heart failure.
    Lobmeyer MT; Gong Y; Terra SG; Beitelshees AL; Langaee TY; Pauly DF; Schofield RS; Hamilton KK; Herbert Patterson J; Adams KF; Hill JA; Aranda JM; Johnson JA
    Pharmacogenet Genomics; 2007 Apr; 17(4):277-82. PubMed ID: 17496726
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative effects of celiprolol and metoprolol on left ventricular volume in coronary artery disease.
    Silke B; Verma SP; Frais MA; Reynolds G; Taylor SH
    Br J Clin Pract Suppl; 1985 Jun; 40():45. PubMed ID: 2864063
    [No Abstract]   [Full Text] [Related]  

  • 14. Beta blockers in systolic heart failure: do physicians need more courage?
    Yilmaz MB; Refiker M
    Am Heart J; 2007 Nov; 154(5):e23; author reply e25. PubMed ID: 17967570
    [No Abstract]   [Full Text] [Related]  

  • 15. The role of the new beta-blockers in treating cardiovascular disease.
    Weber MA
    Am J Hypertens; 2005 Dec; 18(12 Pt 2):169S-176S. PubMed ID: 16373195
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Indications of beta-blockers in paediatric cardiology (author's transl)].
    Gérard R; Gatau-Pelanchon J; Lévy S; Faugère G; Valeix B
    Ann Cardiol Angeiol (Paris); 1982; 31(2):139-42. PubMed ID: 6125123
    [No Abstract]   [Full Text] [Related]  

  • 17. [Temporal trends in pharmacological therapy in the IN-CHF registry from 1995 to 2005].
    Fabbri G; Gorini M; Maggioni AP; Di Lenarda A;
    G Ital Cardiol (Rome); 2007 Feb; 8(2):102-6. PubMed ID: 17402354
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Pharmacology of beta-receptor blockers].
    Schmitz W
    Z Kardiol; 1996; 85 Suppl 7():5-9. PubMed ID: 9082683
    [TBL] [Abstract][Full Text] [Related]  

  • 19. S-metoprolol: the 2008 clinical review.
    Dasbiswas A; Shinde S; Dasbiswas D
    J Indian Med Assoc; 2008 Apr; 106(4):259-62. PubMed ID: 18828349
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [beta-Adrenoblockers in cardiology: metoprolol succinate].
    Zateĭshchikov DA; Dankovtseva EN
    Kardiologiia; 2007; 47(8):87-92. PubMed ID: 18260921
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.